Anti-SARS-CoV-2 RBD Antibody (Bamlanivimab) (CAT#: VAb-057SX)

• Product Overview
• Bamlanivimab is a neutralizing IgG1κ mAb directed against the SARS-CoV-2 spike (S) protein, which is described to block viral entry into human cells.

• Target
• SARS-CoV-2

• Source
• XtenCHO

• Clonality
• MAb

• Isotype
• Human IgG

• Concertration
• 1 mg/ml

• Immunogen
• Recombinant SARS-CoV-2 RBD protein

• Type
• Antibody

• Form
• Liquid

• Buffer Solution
• PBS, pH 7.5.

• Applications
• Used for WB, ELISA, IHC-P, FCM, ICC/IF, IP.

• Storage
• Store at 2°C to 8°C short term, -20°C long term.

• Introduction
• Bamlanivimab (LY-CoV555, also known as LY3819253), is a synthetic monoclonal antibody (mAb) derived from one of the first blood samples in the United States from a patient who recovered from COVID-19. Bamlanivimab is a neutralizing IgG1κ mAb directed against the SARS-CoV-2 spike (S) protein, which is described to block viral entry into human cells.

• Alternative Names
• Bamlanivimab, LY-CoV555, LY3819253